Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115,069 | 135,471 | 153,521 | 171,002 | 79,741 |
| Receivables | 4,665 | 5,428 | 4,072 | 782 | 3,330 |
| TOTAL | $130,589 | $155,071 | $173,176 | $191,620 | $105,492 |
| Non-Current Assets | |||||
| PPE Net | 10,231 | 7,577 | 5,746 | 3,784 | 1,110 |
| Other Non-Current Assets | 5,525 | 3,246 | 2,757 | 2,875 | 2,512 |
| TOTAL | $15,756 | $10,823 | $8,503 | $6,659 | $3,622 |
| Total Assets | $146,345 | $165,894 | $181,679 | $198,279 | $109,114 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 960 | 2,619 | 1,082 | 396 | 906 |
| Accrued Expenses | 16,589 | 15,836 | 15,192 | 15,355 | 10,846 |
| TOTAL | $18,368 | $19,321 | $17,112 | $16,579 | $12,526 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,995 | 1,655 | 1,153 | 1,363 | 1,578 |
| TOTAL | $3,995 | $1,655 | $1,153 | $1,363 | $1,578 |
| Total Liabilities | $22,363 | $20,976 | $18,265 | $17,942 | $14,104 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,432 | 1,429 | 1,428 | 1,429 | 1,421 |
| Common Shares | 215 | 214 | 214 | 214 | 182 |
| Retained earnings | -764,101 | -741,329 | -721,014 | -702,418 | -684,125 |
| TOTAL | $123,982 | $144,918 | $163,414 | $180,337 | $95,010 |
| Total Liabilities And Equity | $146,345 | $165,894 | $181,679 | $198,279 | $109,114 |